vector: a market access and development company

A MARKET ACCESS

AND DEVELOPMENT COMPANY

Dear colleagues, Once upon a time there becomes a moment, when you realize, that your particular knowledge and experience, a quintessence of all your achievements, are able to make something really meaningful. And this is how the story of our company begins. We united professionals in business, international affairs, with legal, medical and educational background from different countries to benefit from the synergy of knowledge and to ensure the access to innovative health technologies in Eastern Europe. Building a bridge between patients, governments, businesses and professional communities we maintain a sustainable development of healthcare market. Collaborating with European Union, Council of Europe and experts from different European institutions, Vector implements the most progressive market access and market development mechanisms. And you’ll find different examples of unprecedented and invincible actions in this presentation. However, we believe, that the most important challenges are still in our future. And I look forward to build successful working relationship with the best manufacturers and distributors of ethical, and patient-oriented health technologies here. Those, interested to share the fundamental European values.

With all my best regards,

Eugeny Nayshtetik, MIB, MM, MSoc CEO and co-founder of Vector Ltd

Vector: a market access and market development company

MODERN

DYNAMIC PROFESSIONAL

EUROPEAN INVINCIBLE

CREATIVE

to provide access to state-‐of-‐the-‐art healthcare technologies to ensure the fundamental human rights


MISSION

to be the most trusted provider of market access and market development tools in Eastern European healthcare


VISION

OUR VALUES


LIFE HUMAN RIGHTS

RULE OF LAW

SUSTAINABLE DEVELOPMENT

SELF-‐REGULATION AND ETHICS In our pracMce we are guided by: •  IFPMA Code of Prac:ce1

•  Criminal Law Conven:on on Corrup:on2 •  Civil Law Conven:on on Corrup:on3 •  Ukrainian Act on the Preven:on and Comba:ng of Corrup:on4

•  US Foreign Corrupt Prac:ces Act (FCPA)5

•  UK Bribery Act 20106


1 hOp://www.ifpma.org/ethics/ifpma-‐code-‐of-‐prac:ce/ifpma-‐code-‐of-‐prac:ce.html 2 hOp://conven:ons.coe.int/Treaty/en/Trea:es/Html/173.htm 3 hOp://conven:ons.coe.int/Treaty/en/Trea:es/Html/174.htm 4 hOp://zakon4.rada.gov.ua/laws/show/3206-‐17 5 hOp://www.jus:ce.gov/criminal/fraud/fcpa/ 6 hOp://www.legisla:on.gov.uk/ukpga/2010/23/contents

-‐  Interna:onal law monitoring and implementa:on

-‐  Diplomacy -‐  Governmental Affairs

-‐  Business development -‐  Licensing and TT -‐  IP rights protec:on -‐  Mul:-‐year planning -‐  Frame agreements

-‐  PhE and Epi studies -‐  Localiza:on of foreign data -‐  Expert networking and KOL

management -‐  Tailor made solu:ons

development


HOW DO WE ACT?

por^olio of our achievements

SUCCESS STORIES

Tuberculosis

2001-‐2007: market development project with -‐ awareness campaign on tuberculosis7,8,9:

ü  origina:on of pa:ents increased on 25% ü  adherence to treatment increases on 30% ü  preven:ve measures were implemented


7 hOp://tb.org.ua/about.html 8 hOp://www.path.org/projects/tuberculosis_control_in_ukraine_ataglance.php 9 hOp://wwwnc.cdc.gov/eid/ar:cle/12/5/05-‐1103_ar:cle.htm

Gaucher Disease

2008-‐2009: market access project with -‐ the most fast-‐tracking regional program development in Ukraine and further bridging to the State budget10: 1 pa:ent was covered with a treatment in only 4 month from the beginning of ac:vi:es -‐ op:miza:on of Interna:onal Cerezyme Access Program implementa:on in Ukraine


10 Decision of Kharkiv Oblast Council №1076-‐V from 29.01.2009

HIV/AIDS

201011: market access project with -‐ Atripla was included in Na:onal HIV program just in 2 months afer market authoriza:on -‐ Isentress was included in Na:onal HIV program in 12 months afer market authoriza:on -‐ Voluntary license on Stocrin (efavirenz) was nego:ated with local manufacturer


11 hOp://zakon4.rada.gov.ua/laws/show/1026-‐17

Vaccines

201112: market access project with -‐ Gardasil was included in Na:onal Immuniza:on Plan (NIP) as recommended vaccine afer 12 months of ac:vi:es

2011: market access project with -‐ Prevenar 7/13 was included in NIP as recommended vaccine afer 4 months of ac:vi:es


12 hOp://zakon4.rada.gov.ua/laws/show/z1159-‐11

Comment on RAP/Rcha/UKR/5(2013)


•  The world’s first comment on na:onal report on implementa:on of

the ar:cle 11 of the European Social Charter13

•  High quality of evidence on example of 3 therapeu:c areas: –  Vaccina:on –  Haemophilia –  Hepa::s C

13 hOp://www.coe.int/t/dghl/monitoring/socialcharter/Repor:ng/StateReports/CommentsAllUkrainianCouncil2013_en.pdf

WriZen declaraMon No. 544


14 hOp://assembly.coe.int/ASP/Doc/XrefViewPDF.asp?FileID=19932&Language=EN 15 hOp://en.wikipedia.org/wiki/Jim_Dobbin 16 hOp://en.wikipedia.org/wiki/Alexander_Scrymgeour,_12th_Earl_of_Dundee 17 hOp://en.wikipedia.org/wiki/John_PrescoO 18 hOp://de.wikipedia.org/wiki/Viola_von_Cramon-‐Taubadel 19 hOp://assembly.coe.int/ASP/Doc/XrefDocDetails_E.asp?FileID=19932

The first European document, which calls to budget realloca:on to ensure the human rights in Ukrainian health care14

The declara:on was signed by ‘stars’ of European poli:cal establishment: –  Jim Dobbin15

–  Alexander Scrymgeour (The Earl of DUNDEE)16

–  John PrescoO17

–  Viola von Cramon-‐Taubadel18

and also by representa:ves of19: –  11 na:onal delega:ons –  All European poli:cal groups –  10 commiOees (from 11) and 12 sub-‐commiOees (from 20)

Let us pass your market access pi^alls!

40-‐g Frunze St., 3rd entrance, 2nd floor, Kyiv, 04080, Ukraine +380 50 444 82 74


vector: a market access and development company

Health & Medicine

ourvalues vector

ons development vector

onin ukraine vector

cofounder of vector

market development mechanisms

european union

different countries

progressive market access